Evidence map›Paper›PMID 38671471›Full record

ArticleJournal of ovarian research2024

Yu Linzhu alleviates primary ovarian insufficiency in a rat model by improving proliferation and energy metabolism of granulosa cells through hif1α/cx43 pathway.

Xin Ruan, Pengxu Wang, Maolin Wei, Qingqing Yang, Xiaoying Dong

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xin RuanDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Capital Medicine University, Beijing, 100069, China.
Pengxu WangDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Capital Medicine University, Beijing, 100069, China.
Maolin WeiDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Capital Medicine University, Beijing, 100069, China.
Qingqing YangDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Capital Medicine University, Beijing, 100069, China.
Xiaoying DongDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Capital Medicine University, Beijing, 100069, China. Softsongs@126.com.
Beijing Hospital of Traditional Chinese Medicine · CN

Funding

Beijing Nature Foundation 7212162Beijing Traditional Chinese medicine torch inheritance "3+3" project 2012-SZ-C-41National Natural Science Foundation of China 81503607
6 · The paper itself

Abstract

backgroundYu Linzhu (YLZ) is a classical Chinese traditional formula, which has been used for more than 600 years to regulate menstruation to help pregnancy. However, the mechanism of modern scientific action of YLZ needs to be further studied.

methodsThirty SD female rats were divided into three groups to prepare the blank serum and drug-containing serum, and then using UHPLC-QE-MS to identify the ingredients of YLZ and its drug-containing serum. Twenty-four SD female rats were divided into four groups, except the control group, 4-vinylcyclohexene dicycloxide (VCD) was intraperitoneally injected to establish a primary ovarian insufficiency (POI) model of all groups. Using vaginal smear to show that the estrous cycle of rats was disturbed after modeling, indicates that the POI model was successfully established. The ELISA test was used to measure the follicle-stimulating hormone (FSH), estradiol (E2), and anti-Mullerian hormone (AMH) levels in the serum of rats. HE stain was used to assess the morphology of ovarian tissue. The localization and relative expression levels of CX43 protein were detected by tissue immunofluorescence. Primary ovarian granulosa cells (GCs) were identified by cellular immunofluorescence. CCK8 was used to screen time and concentration of drug-containing serum and evaluate the proliferation effect of YLZ on VCD-induced GCs. ATP kit and Seahorse XFe24 were used to detect energy production and real-time glycolytic metabolism rate of GCs. mRNA and protein expression levels of HIF1α, CX43, PEK, LDH, HK1 were detected by RT-PCR and WB.

resultsUHPLC-QE-MS found 1702 ingredients of YLZ and 80 constituents migrating to blood. YLZ reduced the FSH while increasing the AMH and E2 levels. In ovarian tissues, YLZ improved ovarian morphology, follicle development, and the relative expression of CX43. In vitro studies, we found that YLZ increased the proliferative activity of GCs, ATP levels, glycolytic metabolic rate, HIF1α, CX43, PEK, HK1, LDH mRNA, and protein levels.

conclusionsThe study indicated that YLZ increased the proliferation and glycolytic energy metabolism of GCs to improve follicular development further alleviating ovarian function.

Indexed as

Cell ProliferationConnexin 43Disease Models, AnimalDrugs, Chinese HerbalEnergy MetabolismGranulosa CellsHypoxia-Inducible Factor 1, alpha SubunitPrimary Ovarian InsufficiencyAnimalsFemaleRatsRats, Sprague-DawleySignal TransductionConnexin 43Drugs, Chinese HerbalHif1a protein, ratHypoxia-Inducible Factor 1, alpha SubunitFollicular developmentGranulosa cellsHIF1α /CX43 PathwayPrimary Ovarian Insufficiency (POI)Yu Linzhu (YLZ)

Identifiers

PMID38671471
PMCPMC11046760
OpenAlexW4395675397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.